Facebook Linkedin RSS Twitter Youtube
Home 2024

Lonza

Lonza Expands Service Offering for Spray-Dried Biologics for Pulmonary Delivery
Bioprocessing

Lonza Expands Service Offering for Spray-Dried Biologics for Pulmonary Delivery

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

Lack of Single-Use Standardization a Challenge for Biopharma
Bioprocessing

Lack of Single-Use Standardization a Challenge for Biopharma

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing
Bioprocessing

Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing

Cell Culture Media System
New Products

Cell Culture Media System

Lonza Enters Bispecific Antibody Collaboration with ABL Bio
Bioprocessing

Lonza Enters Bispecific Antibody Collaboration with ABL Bio

Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza
News

Biomanufacturing Facility Upgrades at Catalent, Recipharm, and Lonza

Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering
Drug Discovery

Lonza Collaborates with Cristal Therapeutics and McSAF to Expand Bioconjugates Offering

Growth of Artificial Intelligence in Pharma Manufacturing
Artificial Intelligence

Growth of Artificial Intelligence in Pharma Manufacturing

Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration
Bioprocessing

Antibody Drug Conjugates Form Basis of Lonza and AbTis Collaboration

123...16Page 2 of 16
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.